PharmaShots | Incisive News in 3 Shots

Subscribe Now

Paracrine

Merck Reports Results of Arpraziquante in P-III Clinical Trial for the Treatment of Schistosomiasis

Merck Reports Results of Arpraziquante in P-III Clinical Trial for the Treatment of Schistosomiasis

November 17, 2021

PharmaShots Interview: Paracrine's Christopher J. Calhoun Shares Insight on the First Autologous, Device-Based Cell Therapy Platform

PharmaShots Interview: Paracrine's Christopher J. Calhoun Shares Insight on the First Autologous, Device-Based Cell Therapy Platfo...

November 16, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us